Chris Sandburg
Recent Articles by Chris Sandburg
- Todos Medical (TOMDF) Inks Transformative CBD Supply Deal After Hours
- Todos Medical (TOMDF) The Ultimate Pandemic Stock
- Todos (TOMDF) Leapfrogs Applied DNA (APDN) and Leads in the MonkeyPox Testing Race
- New CDC Guidelines Revive COVID Therapeutic Need for VERU TOMDF CYDY
- Monkeypox Stocks Heating Up the Charts: TOMDF APDN CODX
- Glaxo’s New Focus After Haleon Spinoff Shines a Light on CytoDyn (OTCMKTS: CYDY) as a Takeover Target
- Hemostemix Transforming Limbs to Life
- Feuerstein's Flab on Northwest Bio (NWBO) Dives Stock on Meritless Claims After Nailing Primary Endpoint
- Veru’s (NASDAQ: VERU) Repurposed COVID-19 Drug Facing Uphill Battle for EUA
- CytoDyn (CYDY) Board Starts Anew with Dramatic Cleaning of the Top Leadership
Recent Comments by Chris Sandburg
- "The essence of your argument seems to be centered around expectations. NP has clearly missed some self imposed deadlines, but these misses pale in co" on CytoDyn’s Preliminary Phase 1b/2 Cancer Results Likely to Receive Breakthrough Therapy Designation (BTD)